You have full text access to this OnlineOpen article

IL-21 Modulates CD4+ CD25+ Regulatory T-Cell Homeostasis in Experimental Autoimmune Encephalomyelitis

  1. W.-H. Piao1,
  2. Y. H. Jee1,2,
  3. R. L. Liu1,
  4. S. W. Coons1,
  5. M. Kala1,
  6. M. Collins3,
  7. D. A. Young3,
  8. D. I. Campagnolo1,
  9. T. L. Vollmer1,
  10. X.-F. Bai4,
  11. A. La Cava5,
  12. F.-D. Shi1

Article first published online: 4 DEC 2007

DOI: 10.1111/j.1365-3083.2007.02035.x

Issue

Scandinavian Journal of Immunology

Scandinavian Journal of Immunology

Volume 67, Issue 1, pages 37–46, January 2008

Additional Information

How to Cite

Piao, W.-H., Jee, Y. H., Liu, R. L., Coons, S. W., Kala, M., Collins, M., Young, D. A., Campagnolo, D. I., Vollmer, T. L., Bai, X.-F., La Cava, A. and Shi, F.-D. (2008), IL-21 Modulates CD4+ CD25+ Regulatory T-Cell Homeostasis in Experimental Autoimmune Encephalomyelitis. Scandinavian Journal of Immunology, 67: 37–46. doi: 10.1111/j.1365-3083.2007.02035.x

Author Information

  1. 1

    Barrow Neurological Institute, St Joseph’s Hospital and Medical Center, Phoenix, AZ, USA

  2. 2

    Department of Veterinary Medicine, Applied Radiological Science Institute, Cheju National University, Jeju, South Korea

  3. 3

    Wyeth Research, Cambridge, MA, USA

  4. 4

    Department of Pathology, Ohio State University Medical Center, Columbus, OH, USA

  5. 5

    Department of Medicine, University of California Los Angeles, Los Angeles, CA, USA

*Dr F.-D. Shi, Barrow Neurological Institute, St Joseph’s Hospital and Medical Center, 350 West Thomas Road, Phoenix, AZ 85013, USA. E-mail: Fu-Dong.Shi@chw.edu

Publication History

  1. Issue published online: 4 DEC 2007
  2. Article first published online: 4 DEC 2007
  3. Received 16 August 2007; Accepted in revised form 17 September 2007

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (465K)

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Isabela Pedroza-Pacheco, Alejandro Madrigal, Aurore Saudemont, Interaction between natural killer cells and regulatory T cells: perspectives for immunotherapy, Cellular and Molecular Immunology, 2013, 10, 3, 222

    CrossRef

  2. 2
    Massimiliano Sarra, Francesco Pallone, Giovanni Monteleone, Interleukin-21 in chronic inflammatory diseases, BioFactors, 2013, 39, 2
    Direct Link:
  3. 3
    Elisabetta Botti, Andreea N. Boca, Giulia Spallone, Giovanni Monteleone, Antonio Costanzo, The Role of IL-21 in Chronic Inflammatory Skin Diseases, Current Dermatology Reports, 2013, 2, 1, 11

    CrossRef

  4. 4
    A. M. Hanash, L. W. Kappel, N. L. Yim, R. A. Nejat, G. L. Goldberg, O. M. Smith, U. K. Rao, L. Dykstra, I.-K. Na, A. M. Holland, J. A. Dudakov, C. Liu, G. F. Murphy, W. J. Leonard, G. Heller, M. R. M. van den Brink, Abrogation of donor T-cell IL-21 signaling leads to tissue-specific modulation of immunity and separation of GVHD from GVL, Blood, 2011, 118, 2, 446

    CrossRef

  5. 5
    Catherine Larochelle, Jorge Ivan Alvarez, Alexandre Prat, How do immune cells overcome the blood–brain barrier in multiple sclerosis?, FEBS Letters, 2011, 585, 23, 3770

    CrossRef

  6. 6
    John S. Tzartos, Matthew J. Craner, Manuel A. Friese, Karen B. Jakobsen, Jia Newcombe, Margaret M. Esiri, Lars Fugger, IL-21 and IL-21 Receptor Expression in Lymphocytes and Neurons in Multiple Sclerosis Brain, The American Journal of Pathology, 2011, 178, 2, 794

    CrossRef

  7. 7
    Massimiliano Sarra, Eleonora Franzè, Francesco Pallone, Giovanni Monteleone, Targeting interleukin-21 in inflammatory diseases, Expert Opinion on Therapeutic Targets, 2011, 15, 6, 695

    CrossRef

  8. 8
    F. Jadidi-Niaragh, A. Mirshafiey, Th17 Cell, the New Player of Neuroinflammatory Process in Multiple Sclerosis, Scandinavian Journal of Immunology, 2011, 74, 1
    Direct Link:
  9. 9
    Ming-Ou Lu, Jie Zhu, The role of cytokines in Guillain–Barré syndrome, Journal of Neurology, 2011, 258, 4, 533

    CrossRef

  10. You have free access to this content10
    Jesse M. Damsker, Anna M. Hansen, Rachel R. Caspi, Th1 and Th17 cells, Annals of the New York Academy of Sciences, 2010, 1183, 1
    Direct Link:
  11. 11
    M. I. Koenders, W. B. Van Den Berg, Translational Mini-Review Series on Th17 Cells: Are T helper 17 cells really pathogenic in autoimmunity?, Clinical & Experimental Immunology, 2010, 159, 2
    Direct Link:
  12. 12
    Nicolas Delaleu, Ammon B. Peck, Autoimmunity: limited progress for the patient, despite decades of research, Scandinavian Journal of Immunology, 2009, 70, 5
    Direct Link:
  13. 13
    A. Corthay, How do Regulatory T Cells Work?, Scandinavian Journal of Immunology, 2009, 70, 4
    Direct Link:
  14. 14
    Joanne L. Jones, Chia-Ling Phuah, Amanda L. Cox, Sara A. Thompson, Maria Ban, Jacqueline Shawcross, Amie Walton, Stephen J. Sawcer, Alastair Compston, Alasdair J. Coles, IL-21 drives secondary autoimmunity in patients with multiple sclerosis, following therapeutic lymphocyte depletion with alemtuzumab (Campath-1H), Journal of Clinical Investigation, 2009,

    CrossRef

  15. You have free access to this content15
    H. Søndergaard, K. Skak, IL-21: roles in immunopathology and cancer therapy, Tissue Antigens, 2009, 74, 6
    Direct Link:
  16. 16
    Giovanni Monteleone, Francesco Pallone, Thomas T. Macdonald, Interleukin-21 (IL-21)-mediated pathways in T cell-mediated disease, Cytokine & Growth Factor Reviews, 2009, 20, 2, 185

    CrossRef

  17. 17
    M. Fedetz, D. Ndagire, O. Fernandez, L. Leyva, M. Guerrero, C. Arnal, M. Lucas, G. Izquierdo, C. Delgado, A. Alcina, F. Matesanz, Multiple sclerosis association study with the TENR-IL2-IL21 region in a Spanish population, Tissue Antigens, 2009, 74, 3
    Direct Link:
  18. 18
    Rosanne Spolski, Warren J Leonard, The Yin and Yang of interleukin-21 in allergy, autoimmunity and cancer, Current Opinion in Immunology, 2008, 20, 3, 295

    CrossRef

  19. 19
    Roland Tisch, Bo Wang, Immunopathogenesis of Type 1 Diabetes Mellitus, 2008,

    CrossRef

View Full Article (HTML) Get PDF (465K)